Vargeese Chandra 4
4 · Wave Life Sciences Ltd. · Filed Jan 24, 2025
Insider Transaction Report
Form 4
Vargeese Chandra
See Remarks
Transactions
- Exercise/Conversion
Ordinary Shares
2025-01-23$2.48/sh+46,000$114,080→ 233,933 total - Exercise/Conversion
Share Option (right to buy)
2025-01-23−46,000→ 16,422 totalExercise: $2.48Exp: 2025-03-10→ Ordinary Shares (46,000 underlying)
Footnotes (2)
- [F1]Includes 2,872 ordinary shares acquired on January 14, 2025, under the issuer's 2019 Employee Share Purchase Plan.
- [F2]The share options that were exercised via cash purchase in this reportable transaction were fully vested.